RA: Difficult-to-treat cases persist in real world despite intensive treatmentApril 6, 2021Rheumatoid Arthritis
Low cardiorespiratory fitness contributes to excess all-cause mortality in RAApril 6, 2021Rheumatoid Arthritis
MBDA score not sufficiently responsive to assess RA disease activityApril 6, 2021Rheumatoid Arthritis
Additional iguratimod may allow tapering MTX dose in RA with remissionApril 6, 2021Rheumatoid Arthritis
JAK inhibitors vs. rituximab in patients with RA and pulmonary diseaseApril 6, 2021Rheumatoid Arthritis
Sustained remission more likely with biological vs. triple therapy after inadequate response to MTXApril 6, 2021Rheumatoid Arthritis
Rheumatology NewsBimekizumab superior to adalimumab in head-to-head psoriasis studyApril 6, 2021Psoriatic Arthritis
Rheumatology NewsExcess deaths jump 23% in U.S. in 2020, mostly because of COVID-19April 5, 2021COVID-19 Updates
Over half of PsA patients not diagnosed within 2 years of symptom onsetApril 5, 2021Psoriatic Arthritis
